Cadent Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Cadent Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $1,847 - $2,051	29 Added 0.84%	3,468 $221,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $8,213 - $9,316	125 Added 3.77%	3,439 $238,000
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $1,575 - $1,865	23 Added 0.7%	3,314 $0
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $2 - $1,767	23 Added 0.7%	3,291 $234,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $4,647 - $5,118	-64 Reduced 1.92%	3,268 $252,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $204,851 - $245,635	3,332 New	3,332 $243,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $177,391 - $207,791	-2,998 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $20,182 - $21,978	-326 Reduced 9.81%	2,998 $200,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $197,246 - $221,843	3,324 New	3,324 $210,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cadent Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cadent Capital Advisors, LLC with notifications on news.